Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
Journal of Experimental Medicine · 03.07.2023 · 220 (7)
DOI: 10.1084/jem.20221212 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Experimental Medicine, online erschienen am 02.06.2023. Verfasst von Imran Howell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Respiratory Medicine Unit, NIHR Respiratory Biomedical Research Centre, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, National Institutes of Health.
Abstract (Originalsprache)
The field of asthma has undergone a dramatic change in recent years. Advances in our understanding of type 2 airway inflammation have driven the discovery of monoclonal antibodies targeting specific aspects of the immune pathway. In landmark trials, these drugs have shown efficacy in reducing asthma attacks and exposure to oral corticosteroids, important causes of morbidity in people with asthma. Our review explores the key features of type 2 inflammation in asthma and summarizes the clinical trial evidence of the novel monoclonal antibody treatments and future avenues for treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, Respiratory Medicine Unit, NIHR Respiratory Biomedical Research Centre, University of Oxford, Oxford, UK.
ORCID-Profile: Imran Howell, Aleksandra Howell, Ian D Pavord
Förderung
- Department of Health
- National Institutes of Health
Zitieren
APA
Howell, I., Howell, A., & Pavord, I. D. (2023). Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. Journal of Experimental Medicine, 220(7). https://doi.org/10.1084/jem.20221212
Vancouver
Howell I, Howell A, Pavord ID. Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. Journal of Experimental Medicine. 2023;220(7). doi:10.1084/jem.20221212
BibTeX
@article{Howell2023,
author = {Howell, Imran and Howell, Aleksandra and Pavord, Ian D},
title = {Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight},
journal = {Journal of Experimental Medicine},
year = {2023},
volume = {220},
number = {7},
doi = {10.1084/jem.20221212}
}
EUVIMED